BFM
VNRX icon

Boothbay Fund Management’s VolitionRx Ltd VNRX Stock Holding History

Boothbay Fund Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-575
Closed -$38K – 2207
2021
Q2 		$38K Buy
+575
New +$38.9K ﹤0.01% 1785

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Boothbay Fund Management's VNRX Position: Q3 2021 in Review

Boothbay Fund Management sold out of VolitionRx Ltd (VNRX) in Q3 2021, closing a stake of 575 shares — an estimated $38K sold.

Boothbay Fund Management first reported a position in VNRX in Q2 2021 and held it in 1 quarter. The position peaked at $38K in Q2 2021. 39 funds tracked by Wall St. Rank hold VNRX as of Q3 2021.

  • Boothbay Fund Management reported no remaining VolitionRx Ltd position as of Q3 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 575 VolitionRx Ltd shares in Q3 2021, an estimated $38K.
  • Boothbay Fund Management first reported a position in VolitionRx Ltd in Q2 2021 and held it in 1 quarter.
  • Boothbay Fund Management's VolitionRx Ltd position peaked at $38K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.